Cargando…

Thrombomodulin, Plasminogen Activator Inhibitor-1 and Protein C Levels, and Organ Dysfunction in Sepsis

Since endothelial function is closely related to organ dysfunction in sepsis and the relationship among endothelial injury, organ dysfunction, and other biomarkers remains unclear, we aimed to evaluate the correlation among endothelial injury, organ dysfunction, and several biomarkers in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katayama, Shinshu, Koyama, Kansuke, Shima, Jun, Tonai, Ken, Goto, Yuya, Koinuma, Toshitaka, Nunomiya, Shin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Original Clinical Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063963/ https://www.ncbi.nlm.nih.gov/pubmed/32166258 http://dx.doi.org/10.1097/CCE.0000000000000013

Ejemplares similares

Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin
por: Katayama, Shinshu, et al.
Publicado: (2017)

Influence of contrast media on renal function and outcomes in patients with sepsis-associated acute kidney injury: a propensity-matched cohort study
por: Goto, Yuya, et al.
Publicado: (2019)

Time course of immature platelet count and its relation to thrombocytopenia and mortality in patients with sepsis
por: Koyama, Kansuke, et al.
Publicado: (2018)

Body weight definitions for evaluating a urinary diagnosis of acute kidney injury in patients with sepsis
por: Katayama, Shinshu, et al.
Publicado: (2018)

Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study
por: Katayama, Shinshu, et al.
Publicado: (2018)

Biomarker profiles of coagulopathy and alveolar epithelial injury in acute respiratory distress syndrome with idiopathic/immune-related disease or common direct risk factors
por: Koyama, Kansuke, et al.
Publicado: (2019)

Predictive factors for successful INTELLiVENT-ASV® use: a retrospective observational study
por: Katayama, Shinshu, et al.
Publicado: (2020)

Accuracy of two pulse-oximetry measurements for INTELLiVENT-ASV in mechanically ventilated patients: a prospective observational study
por: Katayama, Shinshu, et al.
Publicado: (2021)

Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study
por: Tonai, Ken, et al.
Publicado: (2022)

Single measurement of plasminogen activator inhibitor-1 in sepsis: is it useful for evaluating the severity or prognosis of sepsis?
por: Koyama, Kansuke, et al.
Publicado: (2017)

Hyperlactatemia caused by intra-venous administration of glycerol: A case study
por: Katayama, Shinshu, et al.
Publicado: (2012)

Upper Arm Muscular Echogenicity Predicts Intensive Care Unit-acquired Weakness in Critically Ill Patients
por: Naoi, Tameto, et al.
Publicado: (2022)

Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study
por: Koyama, Kansuke, et al.
Publicado: (2014)

Concurrent treatment with a tumor necrosis factor-alpha inhibitor and veno-venous extracorporeal membrane oxygenation in a post-hematopoietic stem cell transplant patient with idiopathic pneumonia syndrome: a case report
por: Koinuma, Toshitaka, et al.
Publicado: (2014)

Airway opening pressure in an obese ARDS patient: just the start of airway recruitment
por: Katayama, Shinshu, et al.
Publicado: (2023)

Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis
por: Li, Juanzhen, et al.
Publicado: (2022)

Plasma levels of thrombomodulin, plasminogen activator inhibitor-1 and fibrinogen in elderly, diabetic patients with depressive symptoms
por: Gorska-Ciebiada, Malgorzata, et al.
Publicado: (2015)

Thrombomodulin: A Bifunctional Modulator of Inflammation and Coagulation in Sepsis
por: Okamoto, Takayuki, et al.
Publicado: (2012)

The Role of Plasminogen Activator Inhibitor 1 in Predicting Sepsis-Associated Liver Dysfunction: An Observational Study
por: Woźnica-Niesobska, Ewa, et al.
Publicado: (2023)

Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies
por: Kudo, Daisuke, et al.
Publicado: (2021)

Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced DIC
por: Yamakawa, K, et al.
Publicado: (2014)

Adequate application of recombinant thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki
Publicado: (2015)

Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
por: Iba, Toshiaki, et al.
Publicado: (2017)

Roles of neurally adjusted ventilatory assist in improving gas exchange in a severe acute respiratory distress syndrome patient after weaning from extracorporeal membrane oxygenation: a case report
por: Goto, Yuya, et al.
Publicado: (2016)

Pharmacokinetics of Recombinant Human Soluble Thrombomodulin in Disseminated Intravascular Coagulation Patients with Acute Renal Dysfunction
por: Hayakawa, Mineji, et al.
Publicado: (2017)

Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
por: Hoshino, Masami, et al.
Publicado: (2001)

Detecting hypercoagulability in sepsis: thromboelastometry vs thrombomodulin-modified thrombin generation test
por: Osovskikh, VV, et al.
Publicado: (2015)

Increased serum thrombomodulin level is associated with disease severity and mortality in pediatric sepsis
por: Lin, Jainn-Jim, et al.
Publicado: (2017)

Association between thrombomodulin and high mobility group box 1 in sepsis patients
por: Rodrigues, Adriana Teixeira, et al.
Publicado: (2020)

Thrombomodulin gene polymorphism and the occurrence and prognostic value of sepsis acute kidney injury
por: Li, Qin, et al.
Publicado: (2021)

Age-related differences in the survival benefit of the administration of antithrombin, recombinant human thrombomodulin, or their combination in sepsis
por: Wada, Takeshi, et al.
Publicado: (2022)

Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2017)

Circadian Variation of Plasminogen-Activator-Inhibitor-1 Levels in Children with Meningococcal Sepsis
por: Boeddha, Navin P., et al.
Publicado: (2016)

Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis
por: Hoshino, Kota, et al.
Publicado: (2017)

Validating plasminogen activator inhibitor‐1 as a poor prognostic factor in sepsis
por: Hoshino, Kota, et al.
Publicado: (2020)

Chondrocyte Thrombomodulin Protects against Osteoarthritis
por: Kang, Lin, et al.
Publicado: (2023)

Pressure-controlled inverse ratio ventilation as a rescue therapy for severe acute respiratory distress syndrome
por: Kotani, Toru, et al.
Publicado: (2016)

Web-based application for predicting the potential target phenotype for recombinant human thrombomodulin therapy in patients with sepsis: analysis of three multicentre registries
por: Goto, Tadahiro, et al.
Publicado: (2022)

Thrombomodulin as a New Marker of Endothelial Dysfunction in Chronic Kidney Disease in Children
por: Drożdż, Dorota, et al.
Publicado: (2018)

Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes
por: Hasegawa, Daisuke, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o5lqi07v1cbdk43v0s7lcnq811